about
Glucocorticoids for the treatment of anaphylaxisAdrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the communityAdrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the communityGlucocorticoids for the treatment of anaphylaxisManagement and Prevention of AnaphylaxisManaging nut-induced anaphylaxis: challenges and solutionsSystematic review of outcome measures in trials of pediatric anaphylaxis treatmentInternational Consensus (ICON): allergic reactions to vaccinesWorld Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) GuidelinesGuidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panelTemporal Regulation by Innate Type 2 Cytokines in Food Allergies.Clinical Characteristics of Inpatients with Anaphylaxis in ChinaClinical evaluation of pediatric anaphylaxis and the necessity for multiple doses of epinephrine.Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxisPeanut allergy: an overviewAnaphylaxis avoidance and management: educating patients and their caregivers.Anaphylaxis: mechanisms and management.Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology.Celecoxib-associated anaphylaxis.Recognition and management of food-induced anaphylaxis.Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA).Protracted anaphylaxis developed after peginterferon α-2a administration for chronic hepatitis C.NIAID-sponsored 2010 guidelines for managing food allergy: applications in the pediatric populationRecurrent anaphylaxis associated with gonadotropin-releasing hormone analogs: case report and review of the literature.Epinephrine: the drug of choice for anaphylaxis-a statement of the world allergy organization.Pediatric anaphylaxis management in the prehospital setting.Food allergy: immune mechanisms, diagnosis and immunotherapyManagement of anaphylaxis in the emergency setting.Dietary treatment of cows' milk protein allergy in childhood: a commentary by the Committee on Nutrition of the French Society of Paediatrics.The risk and management of anaphylaxis in the setting of immunotherapy.Anaphylaxis in dogs and cats.Optimal treatment of anaphylaxis: antihistamines versus epinephrine.The future of biologics: applications for food allergy.Pearls and Pitfalls in Diagnosing IgE-Mediated Food Allergy.A review of associated controversies surrounding glucocorticoid use in veterinary emergency and critical care.Late reactions in food-allergic children and adolescents after double-blind, placebo-controlled food challenges.A case of fibromyalgia syndrome with anaphylaxis induced by intradermal injection of purified protein derivative.Epinephrine for anaphylaxis: underutilized and unavailableA survey study of index food-related allergic reactions and anaphylaxis management.Recognition and treatment of anaphylaxis in hospital.
P2860
Q24200443-3B20A99D-4329-40D5-813D-18754D73E408Q24201463-23DDD5EF-F402-4049-B450-942C31DD4A64Q24235431-6A50B314-1868-4570-B949-7D283F81D88EQ24236588-157A6951-F368-485A-B935-DDECFB47025DQ26766190-C878E5FF-34A4-4A80-A47E-CF1DD21FB300Q26775864-DC14E214-D1AF-4AA2-A0F0-E214252B35D3Q27025706-2699890C-77DF-4265-A28B-D0D657CF1F40Q27468685-AD57C9F7-D560-4D50-9B77-52AA30020BDAQ28282226-951E8074-B39A-46E8-AE88-8981CB985D04Q28300001-49762341-78A2-4A4D-A2DB-78AFC5948D41Q30244169-43CDBCF5-53ED-4A24-B38B-108976ED273CQ30384820-B94DAD8D-A4E3-439E-8A93-21BDD90FF226Q33162761-D20AB19C-2CC7-4136-989F-80E93EB521CDQ33783268-3EE563A4-6A94-4205-9A6A-9EE258E1AC40Q33846725-993E6ED0-AF02-4AE1-A3A9-EAA2008890BAQ33895403-C86339F8-FA73-478B-A5AC-E4B5533A0324Q34192100-992AFB02-0A56-40B5-9DAF-86C3D56B82EAQ34423618-D47941B0-D60E-4B2A-B86B-25E377E855CCQ34605576-72144E16-C83C-4749-B00F-2D500783FB89Q34986991-3323D0BB-0E05-4E34-93F9-B7AA0C90CE13Q35087159-B6D00566-0198-459C-B2B2-1442C2671E0EQ35152412-E9ABE516-AF37-40BF-915C-72CDCB94A962Q35530004-F85B59EF-7EB5-4942-AFDF-9F2A3055F53CQ36662921-1482307F-FE4C-4A7D-877A-8ABCE9046535Q36882535-578367E0-9E85-4518-A528-50B5F8CB0B38Q37397221-0015202C-A533-4B9B-8F48-DE64BCE64EFBQ37442005-2AE1A8B2-B701-4F49-96EC-E8FF560D21AFQ37729047-EC73D687-8698-4779-B58C-39D0E8D53612Q37960656-05CD0C53-F649-4445-A5FC-7D3973FED90BQ38066677-757A601A-B980-4615-A121-33252555B62BQ38121593-D5652AE7-A0D6-42E8-9A21-6E15FAAE6AE8Q38241636-90D72ED6-11FE-4F28-AB0F-822E0E9D736CQ38348057-47498523-D2B9-4899-89CA-3F894361C8C6Q38796721-F86AE13A-9C7C-42A6-9812-C01374713B2DQ38816542-BE1E074D-5A6D-4FB6-B53F-F212758E7BE9Q39816454-6E99ABB2-FC90-4F9A-AC42-9BC1952835AFQ40284040-CBFC5025-221A-4070-9659-88F8E7256D0FQ42561325-5CD8ADBF-729C-401D-8D66-55A59A237ECAQ44307339-C66BE388-7B83-43D2-862F-975F692362E9Q45572168-08B37792-4EE7-4EDD-92FA-64E587AB4AC2
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Biphasic anaphylactic reactions.
@ast
Biphasic anaphylactic reactions.
@en
Biphasic anaphylactic reactions.
@nl
type
label
Biphasic anaphylactic reactions.
@ast
Biphasic anaphylactic reactions.
@en
Biphasic anaphylactic reactions.
@nl
prefLabel
Biphasic anaphylactic reactions.
@ast
Biphasic anaphylactic reactions.
@en
Biphasic anaphylactic reactions.
@nl
P1476
Biphasic anaphylactic reactions.
@en
P2093
Phil Lieberman
P304
217-26; quiz 226, 258
P356
10.1016/S1081-1206(10)61217-3
P577
2005-09-01T00:00:00Z